Accuray Incorporated logo

Accuray Incorporated (XEJ)

Market Closed
10 Jun, 20:00
1. 11
+0.01
+0.91%
- Market Cap
- P/E Ratio
0% Div Yield
0 Volume
- Eps
1.1
Previous Close
Day Range
1.1 1.11
Year Range
1.1 2.58
Earnings results expected in 62 days

Summary

XEJ closed yesterday higher at €1.11, an increase of 0.91% from Monday's close, completing a monthly decrease of -6.72% or €0.08. Over the past 12 months, XEJ stock lost -41.27%.
XEJ is not paying dividends to its shareholders.
The last earnings report, released on Apr 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 12, 2025.
The stock of the company had never split.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).
Want to track XEJ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

XEJ Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.
Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

Accuray Announces Convertible Notes Exchange and Refinancing of Existing Credit Facilities

MADISON, Wis. , June 6, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today announced that, after an extensive review over the last several months, including the evaluation of numerous potential financing partners, it has entered into privately negotiated agreements with the holders of its existing 3.75% senior convertible notes due 2026 (the "Notes") to exchange an aggregate of $82.0 million principal amount of Notes for an aggregate of 8,881,579 shares of the Accuray's common stock (the "Shares").

Prnewswire | 5 days ago
Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?

Why Is Accuray (ARAY) Up 17% Since Last Earnings Report?

Accuray (ARAY) reported earnings 30 days ago. What's next for the stock?

Zacks | 1 week ago
Accuray to Participate in the Jefferies Global Healthcare Conference 2025

Accuray to Participate in the Jefferies Global Healthcare Conference 2025

MADISON, Wis. , May 29, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Jefferies Global Healthcare Conference 2025.

Prnewswire | 1 week ago

Accuray Incorporated (XEJ) FAQ

What is the stock price today?

The current price is €1.11.

On which exchange is it traded?

Accuray Incorporated is listed on NASDAQ (NGS).

What is its stock symbol?

The ticker symbol is XEJ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

What is the earnings per share?

The EPS is 0.

When is the next earnings date?

The next earnings report will release on Aug 12, 2025.

Has Accuray Incorporated ever had a stock split?

No, there has never been a stock split.

Accuray Incorporated Profile

Medical - Specialties Industry
Healthcare Sector
Ms. Suzanne Winter M.B.A. CEO
XSTU Exchange
US0043971052 ISIN
US Country
987 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Accuray Incorporated is a leading innovator in the field of precision radiation oncology, providing advanced radiosurgery and radiation therapy systems worldwide. Founded in 1990 and based in Madison, Wisconsin, the company's pioneering solutions are designed to enhance cancer treatment by targeting tumors with high precision. Accuray’s global reach extends across the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and the rest of the Asia Pacific region. The company is committed to improving patient outcomes by offering cutting-edge technology for the treatment of primary and metastatic tumors outside the brain, among other applications. In addition to developing and manufacturing its products, Accuray Incorporated offers a comprehensive range of support services including post-contract customer support, installation, training, and professional services to ensure the effective use and maintenance of its systems.

Products and Services

  • CyberKnife System

This innovative robotic stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) system is at the forefront of Accuray’s offerings. The CyberKnife System is designed for the treatment of primary and metastatic tumors located outside the brain. It is particularly effective for tumors on or near the spine and in regions such as the breast, kidney, liver, lung, pancreas, and prostate. Utilizing robotic technology, the system delivers highly precise treatment, minimizing damage to surrounding healthy tissue.

  • TomoTherapy System, including the Radixact System

The TomoTherapy and Radixact Systems represent a significant advancement in the delivery of radiation therapy, enabling clinicians to perform ultra-precise treatments for a wide range of cancers. These systems feature integrated radiation treatment planning, delivery, and data management capabilities. The high level of precision and efficiency allows for treating approximately 50 patients per day, making it a pivotal tool in high-volume treatment centers.

  • iDMS Data Management System

Accuray’s iDMS Data Management System is designed to enhance the efficiency of treatment planning and delivery by providing a fully integrated suite for managing patient data and treatment plans. This system streamlines the workflow, facilitating a more seamless operation from planning through treatment.

  • Accuray Precision Treatment Planning System

The Accuray Precision Treatment Planning System is tailored to support the detailed and complex planning required for delivering precise radiation therapy. By offering sophisticated data management and planning tools, this system aids clinicians in creating optimized treatment strategies for their patients.

  • Professional Services

In addition to its pioneering technology, Accuray Incorporated provides a comprehensive suite of professional services. These include post-contract customer support, which ensures that all systems are maintained to the highest standards, as well as installation and training services. Through these offerings, Accuray empowers healthcare providers to maximize the benefits of its systems for patients, thereby enhancing treatment outcomes and operational efficiency.

Contact Information

Address: 1240 Deming Way
Phone: 608 824 2800